Dr. Yasser El-Sayed, MD
Palo Alto, CA
Affiliated with a Castle Connolly Top Hospital
Who is Dr. El-Sayed, Maternal & Fetal Medicine Specialist in Palo Alto, CA?
Where did Dr. El-Sayed go to medical school and complete their residency?
Medical School: Medical College of Wisconsin
Is Dr. El-Sayed board certified as a Maternal & Fetal Medicine Specialist?
Yes, Dr. Yasser El-Sayed, MD is board certified by the American Board of Obstetrics and Gynecology
What languages does Dr. El-Sayed speak?
Dr. El-Sayed and their clinical team can communicate with patients in the following languages:
- Arabic
- English
What conditions does a Maternal & Fetal Medicine Specialist like Dr. El-Sayed typically treat?
As a Maternal & Fetal Medicine Specialist, Dr. El-Sayed diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. El-Sayed. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Other Prenatal Screenings
- Nuchal Translucency Screening
- Prenatal Care
- Additional pregnancy tests
- Special antenatal screenings
- Specific prenatal checks
- NT scan
- First trimester screening ultrasound
- Screening for Down syndrome
ICD-10 Codes:
- Z3689: Encounter for other specified antenatal screening
- Z3682: Encounter for antenatal screening for nuchal translucency
Also known as:
- Antenatal Screening Follow-up
- Other Prenatal Screening Follow-up
- Maternal Screening Follow-up
- Pregnancy Screening Review
ICD-10 Codes:
- Z362: Encounter for other antenatal screening follow-up
Also known as:
- Pregnancy Care for Older Mothers with Previous Births
- Health Problems in Pregnancy
- Advanced Maternal Age Multiple Pregnancies
- Elderly Multigravida Care
- Older Mother with Prior Births Pregnancy Monitoring
ICD-10 Codes:
- O09523: Supervision of elderly multigravida, third trimester
What procedures does a Maternal & Fetal Medicine Specialist like Dr. El-Sayed typically perform?
As a Maternal & Fetal Medicine Specialist, Dr. El-Sayed performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. El-Sayed. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Fetal Non-Stress Test
- Nonstress Test
- Nonstress Test (NST)
- Fetal Heart Rate Monitoring
- NST for Pregnancy
- Baby Heartbeat Test
CPT Codes:
- 59025: Fetal non-stress test
Also known as:
- Diagnostic Amniocentesis
- Chorionic Villus Sampling
- Amniocentesis (amniotic fluid test)
- Chorionic Villus Sampling (CVS)
- Amniotic Fluid Test
- Amnio
- Prenatal Genetic Testing
- CVS Test
- Placenta Biopsy
- Early Pregnancy Genetic Test
CPT Codes:
- 59000: Amniocentesis; diagnostic
- 59015: Chorionic villus sampling, any method
Also known as:
- Comprehensive Prenatal Care (7+ Visits)
- Prenatal Care
- Antepartum Care
- Pregnancy Check-ups
- Maternity Care
- Obstetric Visits
CPT Codes:
- 59426: Antepartum care only; 7 or more visits
Also known as:
- Prenatal Care Visits (4-6)
- Prenatal Care
- Antepartum visits
- Pregnancy check-ups
- Maternity care appointments
CPT Codes:
- 59425: Antepartum care only; 4-6 visits
Also known as:
- IUD Insertion
- Birth Control
- Intrauterine device placement
- IUD placement
- Birth control implant
CPT Codes:
- 58300: Insertion of intrauterine device (IUD)
Does Dr. El-Sayed accept my insurance?
Dr. El-Sayed accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. El-Sayed accept in Palo Alto, CA?
Dr. El-Sayed in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Blue Shield of California
Centene Corporation
Cigna Group
CVS Health (formerly Aetna)
Federal government of the United States
Health Plan of San Joaquin
Medicaid
State of California
UMR Administered Payer
UnitedHealth Group
View All Insurances
Where is Dr. El-Sayed's office located?
What hospitals are Dr. El-Sayed affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. El-Sayed has admitting privileges at the following hospitals:
Recognitions
Publications
Noninvasive in vivo monitoring of tissue-specific global gene expression in humans.
, 2014
In response.
, 2014
Oral misoprostol versus vagil dinoprostone for labor induction in nulliparous women at term.
, 2014
High Rate of Preterm Birth in Pregncies Complicated by Rheumatoid Arthritis
, 2014
Isolated umbilical vein varix with a poor outcome despite close fetal surveillance.
, 2013
A Cost Alysis of Neuraxial Anesthesia to Facilitate Exterl Cephalic Version
, 2013
Effect of magnesium sulfate exposure on term neotes
, 2013
Peripartum outcomes
, 2013
Utilization of available pretal screening and diagnosis: effects of the California screen program
, 2012
Diagnosis and Magement of Arrest Disorders: Duration to Wait
, 2012
Non-invasive pretal measurement of the fetal genome
, 2012
Rectus muscle and visceral peritoneum closure at cesarean delivery and intraabdomil adhesions
Trends in Cesarean Delivery for Twin Births in the United States: 1995-2008 Reply
, 2012
Continuous Glucose Monitoring During Pregncy in Women With Polycystic Ovary Syndrome
, 2012
Trends in Cesarean Delivery for Twin Births in the United States 1995-2008
, 2011
Decreased Circulating Soluble Tie2 Levels
, 2011
Neotal medical admission in a term and late-preterm cohort exposed to magnesium sulfate
MR imaging in cases of antetal suspected appendicitis - a meta-alysis
, 2011
The Effect of Preterm Premature Rupture of Membranes on Neotal Mortality Rates
, 2010
Regiol anesthesia for exterl cephalic version: its time has come
, 2010
Materl-fetal and neotal pharmacogenomics: a review of current literature
, 2010
Oral Misoprostol and Vagil Isosorbide Mononitrate for Labor Induction A Randomized Controlled Trial
, 2010
Single- versus double-layer hysterotomy closure at primary caesarean delivery and bladder adhesions
, 2010
Daily Compared With 8-Hour Gentamicin for the Treatment of Intrapartum Chorioamnionitis A R
, 2010
Cost-effectiveness of exterl cephalic version for term breech presentation
, 2010
Second-Trimester Serum Cytokines in Women Who Develop Spontaneous Preterm Labor at Less than 28
, 2010
Multiple Cytokine Profile in Plasma and Amniotic Fluid in a Mouse Model of Pre-Term Labor
, 2009
Microfluidic digital PCR ebles rapid pretal diagnosis of fetal aneuploidy
, 2009
Successful pregncy and cesarean delivery via noninvasive ventilation in mitochondrial myopathy
, 2009
RANDOMIZED CLINICAL TRIAL OF CERVICAL RIPENING AND LABOR INDUCTION USING ORAL MISOPROSTOL WITH OR
, 2008
Maintence Nifedipine Tocolysis Compared With Placebo A Randomized Controlled Trial
, 2008
Perital outcomes among Asian-white interracial couples
, 2008
Two cases of cholestasis in the first trimester of pregncy after ovarian hyperstimulation
, 2008
Population trends in cesarean delivery for breech presentation in the United States, 1997-2003
, 2008
Antibiotic prophylaxis for prevention of postpartum perineal wound complications - A r
, 2008
Concealed materl blood glucose excursions correlate with birth weight centile.
, 2008
Once daily vs. 8-hour gentamicin dosing for chorioamnionitis
, 2007
Pre-eclampsia and sal CPAP
, 2007
Bacterial flora-typing with targeted, chip-based Pyrosequencing
, 2007
Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor
, 2007
Randomized comparison of intravenous terbutaline vs nitroglycerin for acute intrapartum fetal
, 2007
Cesarean delivery outcomes after a prolonged second stage of labor
, 2007
Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor - A r
, 2007
Perital outcomes after successful and failed trials of labor after cesarean delivery.
, 2007
Use of a community mobile health van to increase early access to pretal care
, 2007
Delivery mode by race for breech presentation in the US
, 2007
Cesarean delivery on materl request: Wise use of finite resources? A view from the trenches
, 2006
Perital outcomes among Asian American and Pacific Islander women
, 2006
Vascular-type disruptive defects in fetuses with homozygous alpha-thalassemia
, 2005
Factors that predict prematurity
, 2005
Randomized comparison of intravenous nitroglycerin and subcutaneous terbutaline
, 2004
Vagil versus ultrasound examition of fetal occiput position during the second stage of labor
, 2004
Cost-effectiveness of a trial of labor after previous cesarean delivery depends on the a priori
, 2004
Neu-Laxova syndrome: Detailed pretal diagnostic and post-mortem findings and literature review
, 2004
Central nervous system lupus and pregncy: 11-year experience at a single center.
, 2002
A longitudil alysis of materl serum insulin-like growth factor I
, 2002
Fetal ear length measurement: a useful predictor of aneuploidy?
, 2002
Mask induction with sevoflurane in a parturient with severe tracheal stenosis
, 2001
Decreased amniotic fluid index in low-risk pregncy
, 2001
Cost-effectiveness of a trial of labor after previous cesarean
, 2001
New therapies for the pregnt patient with diabetes.
, 2001
Ultrasonographic ear length measurement in normal second-and third-trimester fetuses
, 2000
A multicenter, placebo
, 2000
Surgical training in selective pelvic arterial ligation or use of embolization only - Reply
, 2000
Congenital diaphragmatic hernia: the peritalogist's perspective.
, 1999
Pelvic arterial embolization for control of obstetric hemorrhage: A five-year experience
, 1999
Randomized comparison of intravenous nitroglycerin and magnesium sulfate
, 1999
Diltiazem for maintence tocolysis of preterm labor: comparison to nifedipine in a randomized trial.
, 1998
Obstetric and gynecologic care of women with epilepsy
, 1998
INTRATHECAL SUFENTANIL FOR LABOR ALGESIA - SENSORY CHANGES, SIDE-EFFECTS
, 1993
What is Dr. El-Sayed's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. El-Sayed's National Provider Identifier (NPI) number is 1548302482.
What common questions do patients ask about Dr. El-Sayed?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. El-Sayed